Beaumont, Spectrum move ahead with merger
The two Michigan health systems have signed a formal integration agreement, marking the next step in the merger process that was first announced in June.
Feds sue UPMC, heart surgeon for billing multiple surgeries at same time
The False Claims Act litigation also accuses the health system of ignoring or minimizing complaints by employees and staff.
ECRI CEO calls on FDA, industry to revisit COVID-19 medical device EUAs as shortages ebb
Marcus Schabacker spoke about patient safety, cyberattacks in healthcare and risks from the rise of at-home care.
Dr. J. Allen Meadows: How digital inhalers have led to more informed treatment discussions in my practice
Dr. J. Allen Meadows worked with Teva Pharmaceuticals to share his experience with the Digihaler® family of inhalers and accompanying platforms.
The low-down on the latest NSA Member ID and Advanced EOB Requirements
What you need to know about new NSA requirements for Member ID cards & AEOBs to reach compliance.
Actuaries suggest individual insurance premiums won’t see large swings in 2022
There is more information available now about how COVID-19 continues to affect healthcare spending and utilization, unlike the 2021 rate-setting season, and “those impacts are not expected to be material,” according to a report.
AHA presents Congress with laundry list of requests for budget reconciliation bill
The hospital lobby asked that some of the funding be used to address the ongoing labor shortage, to shore up mental health services and address ongoing coverage gaps.
Baxter to buy Hillrom for $10.5B in bid to expand connected care portfolio
Wall Street analysts and investors had thrown cold water on earlier reports of a deal, questioning the price and strategic fit.
Pandemic spurs rise of infections contracted at healthcare facilities
Bloodstream infections associated with central line catheters were responsible for the largest rise in hospital-acquired infections from 2019 to 2020, according to the CDC.
Pfizer, Merck launch large new trials of oral COVID-19 drugs
Both companies are racing to prove their oral antivirals as treatments for COVID-19. Key clinical results could come later this year.